Patent details

EP2361261 Title: CELLS, NUCLEIC ACID CONSTRUCTS, CELLS COMPRISING SAID CONSTRUCTS AND METHODS UTILIZING SAID CELLS IN THE TREATMENT OF DISEASES

Basic Information

Publication number:
EP2361261
PCT Application Number:
PCT/EP/2009/064788
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP097483366
PCT Publication Number:
WO/2010/052313
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CELLS, NUCLEIC ACID CONSTRUCTS, CELLS COMPRISING SAID CONSTRUCTS AND METHODS UTILIZING SAID CELLS IN THE TREATMENT OF DISEASES
French Title of Invention:
CELLULES, PRODUITS DE CONSTRUCTION D'ACIDE NUCLÉIQUE, CELLULES COMPRENANT LESDITS PRODUITS DE CONSTRUCTION ET MÉTHODES UTILISANT LESDITES CELLULES DANS LE TRAITEMENT DE MALADIES
German Title of Invention:
ZELLEN, NUKLEINSÄUREKONSTRUKTE, DIESE KONSTRUKTE ENTHALTENDE ZELLEN UND VERFAHREN ZUR ANWENDUNG DIESER ZELLEN BEI DER BEHANDLUNG VON KRANKHEITEN
SPC Number:

Dates

Filing date:
06/11/2009
Grant date:
27/01/2016
EP Publication Date:
27/01/2016
PCT Publication Date:
14/05/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/08/2011
EP B1 Publication Date:
27/01/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/11/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/03/2022
 
 

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

History of Owners

From:
06/11/2009
To:
04/03/2022

Name:
Tigenix S.A.
Address:
C/ Marconi 1, 28760 Tres Cantos (Madrid), Spain (ES)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
30/03/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
DE LA ROSA Olga
Address:
Spain (ES)

2

Name:
BUESCHER Dirk
Address:
Spain (ES)

3

Name:
LOMBARDO Eleuterio
Address:
Spain (ES)

Priority

Priority Number:
0820397
Priority Date:
07/11/2008
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07K 14/435;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2022/05
Publication date:
01/04/2022
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20220000073A
Date Registered:
04/03/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Baker & McKenzie
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome, Chuo-ku, 541-0045, Osaka-Shi, Osaka, Japan (JP)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
22/10/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
08/03/2022 Outgoing Correspondence 1
04/03/2022 Request For Change 18